Clinical Trial Update: Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR. [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study from Yale assessed cognitive function in kidney transplant patients before and after converting from immediate-release tacrolimus (Prograf) to E…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Envarsus XR (Tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Yale University | Conditions: Kidney Transplant; Complications | EARLY_Phase 1 | Status: COMPLETED